| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/02/2004 | CA2518311A1 Superoxide anion scavenger |
| 09/02/2004 | CA2515610A1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | CA2515480A1 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
| 09/01/2004 | EP1452594A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
| 09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
| 09/01/2004 | EP1452491A1 Titanium-group metal containing high-performance water, and its producing method and apparatus |
| 09/01/2004 | EP1452205A1 Uses of keratinocyte growth factor-2 |
| 09/01/2004 | EP1452167A1 Cosmetic, pharmaceutical and/or dermatological composition comprising an extract of Eperua falcata |
| 09/01/2004 | EP1452166A1 Hair repairing liquid comprising water dispersed with ultrafine particle titanium group metal by plasma underwater discharge and method and system for producing the same |
| 09/01/2004 | EP1452161A1 External preparation for the skin and copolymer to be used therein |
| 09/01/2004 | EP1451308A2 Therapeutic use of aziridino compounds |
| 09/01/2004 | EP1451242A1 Water-in-silicone emulsions |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451202A1 Aryl fused azapolycyclic compounds |
| 09/01/2004 | EP1451192A1 Novel crystalline compound |
| 09/01/2004 | EP1451191A1 Thioether substituted imidazoquinolines |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451187A1 Amide substituted imidazopyridines |
| 09/01/2004 | EP1451186A2 Urea substituted imidazopyridines |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451174A2 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1451144A1 Compositions for treating acne comprising phytandiol amine |
| 09/01/2004 | EP1450872A1 Composition and method for treatment of wounds |
| 09/01/2004 | EP1450867A1 Sterilizing tunnel for pharmaceutical containers |
| 09/01/2004 | EP1450853A1 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 09/01/2004 | EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 09/01/2004 | EP1450829A1 Storage-stable fibrinogen solutions |
| 09/01/2004 | EP1450825A1 Use of selenite-containing compounds to be topically or buccally administered |
| 09/01/2004 | EP1450820A2 Method for treating or preventing inflammatory diseases |
| 09/01/2004 | EP1450804A1 Pharmaceutical formulations comprising an immune response modifier |
| 09/01/2004 | EP1450798A1 Use of an ascomycin for the treatment of blepharitis |
| 09/01/2004 | EP1450792A1 Benzazole derivatives for the treatment of scleroderma |
| 09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/01/2004 | EP1450785A1 Method of treating dermatoses using avermectin compound |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450771A2 Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450760A2 Itch-relieving cosmetic and dermatological preparations |
| 09/01/2004 | EP1450756A1 Surfactant-containing cosmetic cleaning emulsions |
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1261349A4 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/01/2004 | EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/01/2004 | EP1221443B1 Substituted imidazolidinone derivatives |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0984771A4 Stabilized gas-supersaturated emulsions and suspensions |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525859A Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 09/01/2004 | CN1525846A Hair-restoring liquid comprising aqueous dispersion of ultra-fine titanium particles and process and apparatus for producing the same |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1524577A Alkaline fibroblast growth factor pellicle and its production method |
| 09/01/2004 | CN1524556A San Er antibacterial injection medicine |
| 09/01/2004 | CN1524555A Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method |
| 09/01/2004 | CN1524553A Exterior-applied medicine for treating dermatopathy |
| 09/01/2004 | CN1524548A Liquid traditional Chinese medicine for treating skin disease and its preparation process |
| 09/01/2004 | CN1524531A Compound terbinafine hydrochloride composition of skin antibacterial drugs |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1524520A Emergency protective agent for wound |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164307C Chinese-medicinal oral liquid for treating flat wart |
| 09/01/2004 | CN1164304C Medicine for treating white hairs |
| 09/01/2004 | CN1164302C Medicated liquor for curing burn and skin injury and its preparation method |
| 09/01/2004 | CN1164297C Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis |
| 09/01/2004 | CN1164295C Application of agave |
| 09/01/2004 | CN1164290C Dressing for treating scalds and burns and its prepn |
| 09/01/2004 | CN1164288C Medicine composition for treating burns and scalds |
| 09/01/2004 | CN1164287C Composite Chinese medicine for treating burns and scalds |
| 09/01/2004 | CN1164278C Biological preparation for curing burn and its preparation method |
| 09/01/2004 | CN1164258C Easily transdermal membrane capable of promoting regrowth of delicate skin and its preparation method |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/31/2004 | CA2133429C Topical administration of toremifene and its metabolites |
| 08/26/2004 | WO2004072687A2 Method and apparatus for correcting vision using an electro-active phoropter |
| 08/26/2004 | WO2004072284A1 Modulation of insulin like growth factor i receptor expression |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072043A1 Benzyl urea and thiourea derivatives useful as androgen antagonists |
| 08/26/2004 | WO2004072022A1 Compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions |
| 08/26/2004 | WO2004071569A2 Method for preventing local radioreactions |
| 08/26/2004 | WO2004071516A1 Glycyrrhizine-containing percutaneous preparation |
| 08/26/2004 | WO2004071485A1 Surgical implant compprising an anabolic and a corticosteroid |
| 08/26/2004 | WO2004071481A1 Melanogenesis inhibitor and skin preparation containing the same |